Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 2Phase NA 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 65Pancreatic Neoplasms 63Glioma 61Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 44Melanoma 43Head and Neck Neoplasms 43Recurrence 41Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 38Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 28Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Lymphoma, B-Cell 22Sarcoma 21Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Advanced Lung Cancer × Clear all
NCT06928922 2026-01-13

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase EARLY_PHASE1 Recruiting
83 enrolled
Thoracic

Advanced Lung Cancer

NCT06106152 2024-03-26

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase EARLY_PHASE1 Unknown
20 enrolled
Thoracic

Advanced Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡